NCT02858713View on ClinicalTrials.gov

Adherence in Topical Treatment of Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

January 9, 2017

Primary Completion Date

April 29, 2017

Study Completion Date

August 29, 2017

Conditions
Adherence
Interventions
DRUG

Calcipotriene + Betamethasone Dipropionate

Participants received Calcipotriene + Betamethasone Dipropionate once daily when needed for the entire study period.

DEVICE

App

App named MyPso SmarTopTM Version 1.0 (LEO Pharma) was used for 28 days by participants in the intervention arm.

Trial Locations (1)

5000

Department of Dermatology and Allergy Centre, Odense C

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT02858713 - Adherence in Topical Treatment of Psoriasis | Biotech Hunter | Biotech Hunter